|Articles|November 1, 2018
- Pharmaceutical Executive-11-01-2018
- Volume 38
- Issue 11
Pharmaceutical Executive, November 2018 Issue (PDF)
Click the title above to open the Pharmaceutical November 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Pharm Exec's 2019 Pipeline Reportalmost 7 years ago
High-Risk Marketing Violations Draw Scrutinyalmost 7 years ago
Biopharma Business Checkalmost 7 years ago
Patent Protection for Cannabis?almost 7 years ago
Steadying the Path of Good Scienceabout 7 years ago
Southeast Biotech: Rising Tall in the Valleyabout 7 years ago
Fighting for a Streamlined European HTA Schemeabout 7 years ago
Stunted Innovation in Drug Development?about 7 years ago
Country Report: AlgeriaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer
2
Pharma Partnerships Expand as Eli Lilly Announces Strategic Collaborations with MeiraGTx and SanegeneBio
3
Wegovy Demonstrates Reduction in Liver Injury in MASH Patients
4
CMS Unveils Initiative to Cut Medicaid Drug Costs and Expand Access to Affordable Medications
5
